Cáncer Pulmonar. Resúmenes actualizados y construidos dinámicamente desde la base de datos.

Inicio   Etapas   Histología   Mutaciones   Operaciones   Sobrevida
Sobrevida

El estudio de la sobrevida del cáncer (probabilidad de sobrevir un determinado número de meses) es la forma más robusta de estudiar las terapias y factores pronósticos en cáncer. De modo general, representa el resultado de todo el proceso de atención al que es sometido el paciente a lo largo de su vida.
Esta forma de análisis y representación gráfica permite comparar en forma consistente las experiencias obtenidos en otros tiempos o lugares. Cada curva corresponde a un grupo de pacientes que comparten un factor en común (como el sexo, la etapa TNM, el tamaño tumoral, etc). En la medida que pasa el tiempo cada fallecimiento ( evento = muerte) se representa por la caída escalonada de la curva. Ubique el puntero del mouse sobre la barra del evento para obtener detalles.

Ver gráficos de acuerdo a las siguientes variables:
Serie: NSCLC todos 
Censored Case ID 79
Survival Duration = 58,4 months
Cumulative Survival Probability = 65,11%
95%CI of Survival = 69,75 - 59,99
Remaining Patients = 169 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 107
Survival Duration = 55,1 months
Cumulative Survival Probability = 65,5%
95%CI of Survival = 70,11 - 60,4
Remaining Patients = 179 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 174
Survival Duration = 50,6 months
Cumulative Survival Probability = 65,87%
95%CI of Survival = 70,45 - 60,8
Remaining Patients = 186 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 73
Survival Duration = 49,4 months
Cumulative Survival Probability = 66,23%
95%CI of Survival = 70,78 - 61,18
Remaining Patients = 188 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 89
Survival Duration = 49,2 months
Cumulative Survival Probability = 66,59%
95%CI of Survival = 71,11 - 61,56
Remaining Patients = 190 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 133
Survival Duration = 48,4 months
Cumulative Survival Probability = 66,94%
95%CI of Survival = 71,44 - 61,94
Remaining Patients = 192 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 183
Survival Duration = 48,4 months
Cumulative Survival Probability = 67,29%
95%CI of Survival = 71,77 - 62,31
Remaining Patients = 193 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 14
Survival Duration = 46,8 months
Cumulative Survival Probability = 67,65%
95%CI of Survival = 72,09 - 62,69
Remaining Patients = 199 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 33
Survival Duration = 45,9 months
Cumulative Survival Probability = 67,99%
95%CI of Survival = 72,41 - 63,06
Remaining Patients = 201 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 207
Survival Duration = 45,1 months
Cumulative Survival Probability = 68,33%
95%CI of Survival = 72,73 - 63,42
Remaining Patients = 205 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 147
Survival Duration = 44,7 months
Cumulative Survival Probability = 68,67%
95%CI of Survival = 73,04 - 63,78
Remaining Patients = 206 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 71
Survival Duration = 44,4 months
Cumulative Survival Probability = 69%
95%CI of Survival = 73,35 - 64,14
Remaining Patients = 207 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 211
Survival Duration = 42,8 months
Cumulative Survival Probability = 69,34%
95%CI of Survival = 73,66 - 64,5
Remaining Patients = 209 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 93
Survival Duration = 42,1 months
Cumulative Survival Probability = 69,67%
95%CI of Survival = 73,97 - 64,86
Remaining Patients = 213 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 69
Survival Duration = 41,7 months
Cumulative Survival Probability = 70,01%
95%CI of Survival = 74,27 - 65,21
Remaining Patients = 216 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 97
Survival Duration = 41,6 months
Cumulative Survival Probability = 70,33%
95%CI of Survival = 74,57 - 65,56
Remaining Patients = 217 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 172
Survival Duration = 41,5 months
Cumulative Survival Probability = 70,66%
95%CI of Survival = 74,87 - 65,91
Remaining Patients = 218 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 57
Survival Duration = 39,9 months
Cumulative Survival Probability = 70,99%
95%CI of Survival = 75,18 - 66,26
Remaining Patients = 227 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 118
Survival Duration = 39,8 months
Cumulative Survival Probability = 71,3%
95%CI of Survival = 75,47 - 66,6
Remaining Patients = 228 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 102
Survival Duration = 38,1 months
Cumulative Survival Probability = 71,62%
95%CI of Survival = 75,76 - 66,94
Remaining Patients = 234 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 284
Survival Duration = 36,5 months
Cumulative Survival Probability = 71,93%
95%CI of Survival = 76,04 - 67,27
Remaining Patients = 239 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 63
Survival Duration = 34,7 months
Cumulative Survival Probability = 72,23%
95%CI of Survival = 76,32 - 67,59
Remaining Patients = 246 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 55
Survival Duration = 34,5 months
Cumulative Survival Probability = 72,53%
95%CI of Survival = 76,6 - 67,91
Remaining Patients = 248 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 24
Survival Duration = 34,4 months
Cumulative Survival Probability = 72,82%
95%CI of Survival = 76,87 - 68,22
Remaining Patients = 249 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 61
Survival Duration = 33,9 months
Cumulative Survival Probability = 73,12%
95%CI of Survival = 77,14 - 68,54
Remaining Patients = 250 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 255
Survival Duration = 32,8 months
Cumulative Survival Probability = 73,41%
95%CI of Survival = 77,41 - 68,85
Remaining Patients = 253 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 194
Survival Duration = 32,5 months
Cumulative Survival Probability = 73,7%
95%CI of Survival = 77,68 - 69,16
Remaining Patients = 254 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 96
Survival Duration = 32,5 months
Cumulative Survival Probability = 74%
95%CI of Survival = 77,95 - 69,48
Remaining Patients = 255 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 90
Survival Duration = 31,7 months
Cumulative Survival Probability = 74,29%
95%CI of Survival = 78,22 - 69,79
Remaining Patients = 258 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 87
Survival Duration = 31,0 months
Cumulative Survival Probability = 74,58%
95%CI of Survival = 78,49 - 70,1
Remaining Patients = 263 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 159
Survival Duration = 30,0 months
Cumulative Survival Probability = 74,86%
95%CI of Survival = 78,75 - 70,41
Remaining Patients = 269 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 446
Survival Duration = 29,6 months
Cumulative Survival Probability = 75,14%
95%CI of Survival = 79,01 - 70,71
Remaining Patients = 270 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 280
Survival Duration = 28,8 months
Cumulative Survival Probability = 75,42%
95%CI of Survival = 79,27 - 71,01
Remaining Patients = 274 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 221
Survival Duration = 28,2 months
Cumulative Survival Probability = 75,7%
95%CI of Survival = 79,53 - 71,3
Remaining Patients = 276 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 35
Survival Duration = 27,5 months
Cumulative Survival Probability = 75,98%
95%CI of Survival = 79,78 - 71,6
Remaining Patients = 279 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 278
Survival Duration = 25,1 months
Cumulative Survival Probability = 76,25%
95%CI of Survival = 80,03 - 71,89
Remaining Patients = 288 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 119
Survival Duration = 25,0 months
Cumulative Survival Probability = 76,52%
95%CI of Survival = 80,28 - 72,18
Remaining Patients = 290 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 283
Survival Duration = 24,9 months
Cumulative Survival Probability = 76,78%
95%CI of Survival = 80,52 - 72,46
Remaining Patients = 291 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 266
Survival Duration = 24,5 months
Cumulative Survival Probability = 77,05%
95%CI of Survival = 80,77 - 72,74
Remaining Patients = 294 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 19
Survival Duration = 24,2 months
Cumulative Survival Probability = 77,31%
95%CI of Survival = 81,01 - 73,03
Remaining Patients = 296 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 156
Survival Duration = 23,8 months
Cumulative Survival Probability = 77,58%
95%CI of Survival = 81,25 - 73,31
Remaining Patients = 298 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 153
Survival Duration = 23,6 months
Cumulative Survival Probability = 77,84%
95%CI of Survival = 81,49 - 73,59
Remaining Patients = 300 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 100
Survival Duration = 23,0 months
Cumulative Survival Probability = 78,1%
95%CI of Survival = 81,73 - 73,87
Remaining Patients = 302 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 334
Survival Duration = 22,0 months
Cumulative Survival Probability = 78,36%
95%CI of Survival = 81,97 - 74,15
Remaining Patients = 305 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 20
Survival Duration = 21,7 months
Cumulative Survival Probability = 78,62%
95%CI of Survival = 82,21 - 74,42
Remaining Patients = 308 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 106
Survival Duration = 21,6 months
Cumulative Survival Probability = 78,88%
95%CI of Survival = 82,45 - 74,7
Remaining Patients = 309 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 532
Survival Duration = 21,5 months
Cumulative Survival Probability = 79,13%
95%CI of Survival = 82,68 - 74,97
Remaining Patients = 312 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 39
Survival Duration = 21,4 months
Cumulative Survival Probability = 79,39%
95%CI of Survival = 82,92 - 75,25
Remaining Patients = 313 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 105
Survival Duration = 20,9 months
Cumulative Survival Probability = 79,64%
95%CI of Survival = 83,15 - 75,52
Remaining Patients = 317 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 185
Survival Duration = 20,4 months
Cumulative Survival Probability = 79,9%
95%CI of Survival = 83,38 - 75,79
Remaining Patients = 318 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 62
Survival Duration = 18,7 months
Cumulative Survival Probability = 80,15%
95%CI of Survival = 83,61 - 76,07
Remaining Patients = 326 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 241
Survival Duration = 18,6 months
Cumulative Survival Probability = 80,4%
95%CI of Survival = 83,84 - 76,33
Remaining Patients = 327 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 175
Survival Duration = 18,6 months
Cumulative Survival Probability = 80,64%
95%CI of Survival = 84,06 - 76,6
Remaining Patients = 328 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 120
Survival Duration = 18,3 months
Cumulative Survival Probability = 80,89%
95%CI of Survival = 84,29 - 76,86
Remaining Patients = 331 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 77
Survival Duration = 17,3 months
Cumulative Survival Probability = 81,14%
95%CI of Survival = 84,52 - 77,13
Remaining Patients = 337 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 60
Survival Duration = 17,2 months
Cumulative Survival Probability = 81,38%
95%CI of Survival = 84,74 - 77,39
Remaining Patients = 338 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 145
Survival Duration = 16,9 months
Cumulative Survival Probability = 81,62%
95%CI of Survival = 84,96 - 77,65
Remaining Patients = 341 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 269
Survival Duration = 16,6 months
Cumulative Survival Probability = 81,86%
95%CI of Survival = 85,18 - 77,91
Remaining Patients = 343 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 263
Survival Duration = 16,3 months
Cumulative Survival Probability = 82,1%
95%CI of Survival = 85,4 - 78,17
Remaining Patients = 346 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 27
Survival Duration = 16,3 months
Cumulative Survival Probability = 82,34%
95%CI of Survival = 85,61 - 78,42
Remaining Patients = 347 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 166
Survival Duration = 16,1 months
Cumulative Survival Probability = 82,58%
95%CI of Survival = 85,83 - 78,68
Remaining Patients = 348 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 526
Survival Duration = 15,7 months
Cumulative Survival Probability = 82,82%
95%CI of Survival = 86,05 - 78,94
Remaining Patients = 349 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 340
Survival Duration = 15,0 months
Cumulative Survival Probability = 83,06%
95%CI of Survival = 86,26 - 79,2
Remaining Patients = 354 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 270
Survival Duration = 14,6 months
Cumulative Survival Probability = 83,29%
95%CI of Survival = 86,48 - 79,45
Remaining Patients = 355 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 524
Survival Duration = 14,3 months
Cumulative Survival Probability = 83,53%
95%CI of Survival = 86,69 - 79,71
Remaining Patients = 357 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 52
Survival Duration = 14,3 months
Cumulative Survival Probability = 83,76%
95%CI of Survival = 86,91 - 79,96
Remaining Patients = 358 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 154
Survival Duration = 13,9 months
Cumulative Survival Probability = 84%
95%CI of Survival = 87,12 - 80,21
Remaining Patients = 361 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 516
Survival Duration = 13,7 months
Cumulative Survival Probability = 84,23%
95%CI of Survival = 87,33 - 80,47
Remaining Patients = 362 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 521
Survival Duration = 12,8 months
Cumulative Survival Probability = 84,47%
95%CI of Survival = 87,54 - 80,72
Remaining Patients = 364 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 218
Survival Duration = 12,7 months
Cumulative Survival Probability = 84,7%
95%CI of Survival = 87,75 - 80,97
Remaining Patients = 365 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 76
Survival Duration = 12,5 months
Cumulative Survival Probability = 84,93%
95%CI of Survival = 87,96 - 81,23
Remaining Patients = 366 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 216
Survival Duration = 12,4 months
Cumulative Survival Probability = 85,17%
95%CI of Survival = 88,17 - 81,48
Remaining Patients = 367 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 9
Survival Duration = 12,3 months
Cumulative Survival Probability = 85,4%
95%CI of Survival = 88,38 - 81,74
Remaining Patients = 368 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 260
Survival Duration = 12,1 months
Cumulative Survival Probability = 85,63%
95%CI of Survival = 88,59 - 81,99
Remaining Patients = 371 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 236
Survival Duration = 11,9 months
Cumulative Survival Probability = 85,87%
95%CI of Survival = 88,8 - 82,24
Remaining Patients = 372 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 515
Survival Duration = 11,9 months
Cumulative Survival Probability = 86,1%
95%CI of Survival = 89,01 - 82,5
Remaining Patients = 373 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 66
Survival Duration = 11,8 months
Cumulative Survival Probability = 86,33%
95%CI of Survival = 89,22 - 82,75
Remaining Patients = 375 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 25
Survival Duration = 11,6 months
Cumulative Survival Probability = 86,56%
95%CI of Survival = 89,42 - 83
Remaining Patients = 377 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 196
Survival Duration = 11,6 months
Cumulative Survival Probability = 86,79%
95%CI of Survival = 89,63 - 83,25
Remaining Patients = 378 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 139
Survival Duration = 11,6 months
Cumulative Survival Probability = 87,02%
95%CI of Survival = 89,84 - 83,51
Remaining Patients = 379 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 38
Survival Duration = 11,5 months
Cumulative Survival Probability = 87,25%
95%CI of Survival = 90,04 - 83,76
Remaining Patients = 380 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 233
Survival Duration = 11,4 months
Cumulative Survival Probability = 87,49%
95%CI of Survival = 90,25 - 84,01
Remaining Patients = 383 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 473
Survival Duration = 11,1 months
Cumulative Survival Probability = 87,72%
95%CI of Survival = 90,45 - 84,27
Remaining Patients = 384 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 249
Survival Duration = 9,9 months
Cumulative Survival Probability = 87,94%
95%CI of Survival = 90,65 - 84,52
Remaining Patients = 386 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 56
Survival Duration = 9,8 months
Cumulative Survival Probability = 88,17%
95%CI of Survival = 90,86 - 84,77
Remaining Patients = 387 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 549
Survival Duration = 9,6 months
Cumulative Survival Probability = 88,4%
95%CI of Survival = 91,06 - 85,02
Remaining Patients = 388 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 570
Survival Duration = 9,2 months
Cumulative Survival Probability = 88,63%
95%CI of Survival = 91,26 - 85,28
Remaining Patients = 390 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 445
Survival Duration = 9,2 months
Cumulative Survival Probability = 88,86%
95%CI of Survival = 91,46 - 85,53
Remaining Patients = 391 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 95
Survival Duration = 9,1 months
Cumulative Survival Probability = 89,09%
95%CI of Survival = 91,66 - 85,78
Remaining Patients = 392 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 98
Survival Duration = 8,7 months
Cumulative Survival Probability = 89,32%
95%CI of Survival = 91,86 - 86,04
Remaining Patients = 394 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 108
Survival Duration = 8,3 months
Cumulative Survival Probability = 89,54%
95%CI of Survival = 92,06 - 86,29
Remaining Patients = 395 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 51
Survival Duration = 7,6 months
Cumulative Survival Probability = 89,77%
95%CI of Survival = 92,26 - 86,54
Remaining Patients = 397 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 99
Survival Duration = 7,5 months
Cumulative Survival Probability = 90%
95%CI of Survival = 92,46 - 86,8
Remaining Patients = 398 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 240
Survival Duration = 7,4 months
Cumulative Survival Probability = 90,23%
95%CI of Survival = 92,66 - 87,05
Remaining Patients = 399 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 176
Survival Duration = 7,4 months
Cumulative Survival Probability = 90,45%
95%CI of Survival = 92,86 - 87,3
Remaining Patients = 400 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 50
Survival Duration = 6,9 months
Cumulative Survival Probability = 90,68%
95%CI of Survival = 93,05 - 87,56
Remaining Patients = 401 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 288
Survival Duration = 6,9 months
Cumulative Survival Probability = 90,91%
95%CI of Survival = 93,25 - 87,81
Remaining Patients = 402 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 188
Survival Duration = 6,8 months
Cumulative Survival Probability = 91,14%
95%CI of Survival = 93,44 - 88,07
Remaining Patients = 403 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 222
Survival Duration = 6,3 months
Cumulative Survival Probability = 91,36%
95%CI of Survival = 93,64 - 88,33
Remaining Patients = 404 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 144
Survival Duration = 6,0 months
Cumulative Survival Probability = 91,59%
95%CI of Survival = 93,83 - 88,58
Remaining Patients = 405 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 180
Survival Duration = 6,0 months
Cumulative Survival Probability = 91,82%
95%CI of Survival = 94,03 - 88,84
Remaining Patients = 406 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 313
Survival Duration = 5,9 months
Cumulative Survival Probability = 92,05%
95%CI of Survival = 94,22 - 89,1
Remaining Patients = 407 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 262
Survival Duration = 5,9 months
Cumulative Survival Probability = 92,27%
95%CI of Survival = 94,42 - 89,35
Remaining Patients = 408 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 275
Survival Duration = 5,8 months
Cumulative Survival Probability = 92,5%
95%CI of Survival = 94,61 - 89,61
Remaining Patients = 409 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 296
Survival Duration = 5,7 months
Cumulative Survival Probability = 92,73%
95%CI of Survival = 94,8 - 89,87
Remaining Patients = 410 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 527
Survival Duration = 5,4 months
Cumulative Survival Probability = 92,95%
95%CI of Survival = 94,99 - 90,13
Remaining Patients = 411 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 261
Survival Duration = 5,3 months
Cumulative Survival Probability = 93,18%
95%CI of Survival = 95,18 - 90,39
Remaining Patients = 412 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 146
Survival Duration = 5,3 months
Cumulative Survival Probability = 93,41%
95%CI of Survival = 95,37 - 90,65
Remaining Patients = 413 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 350
Survival Duration = 4,9 months
Cumulative Survival Probability = 93,64%
95%CI of Survival = 95,56 - 90,92
Remaining Patients = 414 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 531
Survival Duration = 4,8 months
Cumulative Survival Probability = 93,86%
95%CI of Survival = 95,75 - 91,18
Remaining Patients = 415 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 163
Survival Duration = 4,6 months
Cumulative Survival Probability = 94,09%
95%CI of Survival = 95,94 - 91,44
Remaining Patients = 416 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 94
Survival Duration = 4,5 months
Cumulative Survival Probability = 94,32%
95%CI of Survival = 96,12 - 91,71
Remaining Patients = 417 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 138
Survival Duration = 4,2 months
Cumulative Survival Probability = 94,55%
95%CI of Survival = 96,31 - 91,97
Remaining Patients = 418 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 29
Survival Duration = 4,0 months
Cumulative Survival Probability = 94,77%
95%CI of Survival = 96,5 - 92,24
Remaining Patients = 419 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 67
Survival Duration = 3,8 months
Cumulative Survival Probability = 95%
95%CI of Survival = 96,68 - 92,51
Remaining Patients = 420 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 478
Survival Duration = 3,5 months
Cumulative Survival Probability = 95,23%
95%CI of Survival = 96,86 - 92,77
Remaining Patients = 421 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 541
Survival Duration = 3,4 months
Cumulative Survival Probability = 95,45%
95%CI of Survival = 97,04 - 93,04
Remaining Patients = 422 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 254
Survival Duration = 3,4 months
Cumulative Survival Probability = 95,68%
95%CI of Survival = 97,22 - 93,31
Remaining Patients = 423 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 109
Survival Duration = 3,1 months
Cumulative Survival Probability = 95,91%
95%CI of Survival = 97,4 - 93,59
Remaining Patients = 424 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 279
Survival Duration = 2,7 months
Cumulative Survival Probability = 96,14%
95%CI of Survival = 97,58 - 93,86
Remaining Patients = 425 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 34
Survival Duration = 2,7 months
Cumulative Survival Probability = 96,36%
95%CI of Survival = 97,76 - 94,13
Remaining Patients = 426 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 23
Survival Duration = 2,7 months
Cumulative Survival Probability = 96,59%
95%CI of Survival = 97,93 - 94,41
Remaining Patients = 427 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 277
Survival Duration = 2,3 months
Cumulative Survival Probability = 96,82%
95%CI of Survival = 98,1 - 94,69
Remaining Patients = 428 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 149
Survival Duration = 2,3 months
Cumulative Survival Probability = 97,05%
95%CI of Survival = 98,27 - 94,97
Remaining Patients = 429 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 569
Survival Duration = 2,2 months
Cumulative Survival Probability = 97,27%
95%CI of Survival = 98,44 - 95,25
Remaining Patients = 430 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 237
Survival Duration = 2,1 months
Cumulative Survival Probability = 97,5%
95%CI of Survival = 98,61 - 95,53
Remaining Patients = 431 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 609
Survival Duration = 2,0 months
Cumulative Survival Probability = 97,73%
95%CI of Survival = 98,77 - 95,82
Remaining Patients = 432 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 239
Survival Duration = 2,0 months
Cumulative Survival Probability = 97,95%
95%CI of Survival = 98,93 - 96,11
Remaining Patients = 433 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 40
Survival Duration = 1,8 months
Cumulative Survival Probability = 98,18%
95%CI of Survival = 99,09 - 96,4
Remaining Patients = 434 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 45
Survival Duration = 1,7 months
Cumulative Survival Probability = 98,41%
95%CI of Survival = 99,24 - 96,69
Remaining Patients = 435 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 287
Survival Duration = 1,6 months
Cumulative Survival Probability = 98,64%
95%CI of Survival = 99,39 - 96,99
Remaining Patients = 436 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 286
Survival Duration = 1,5 months
Cumulative Survival Probability = 98,86%
95%CI of Survival = 99,53 - 97,29
Remaining Patients = 437 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 143
Survival Duration = 1,2 months
Cumulative Survival Probability = 99,09%
95%CI of Survival = 99,66 - 97,6
Remaining Patients = 438 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 37
Survival Duration = 1,1 months
Cumulative Survival Probability = 99,32%
95%CI of Survival = 99,78 - 97,9
Remaining Patients = 439 de 440 en la serie Serie: NSCLC todos 
Censored Case ID 74
Survival Duration = 0,9 months
Cumulative Survival Probability = 99,55%
95%CI of Survival = 99,89 - 98,19
Remaining Patients = 440 de 440 en la serie
Ficha técnica
Información actualizada en forma dinámica
Censo: Certificado de Defunción, Registro Civil Chile.
Curva de Kaplan Meier, ver "Non-parametric estimation from incomplete observations. Kaplan, E. L. and Meier. 1958, Journal of the American Statistical Association, pp. P.53, 457–481 and 562–563".
Intervalos de confianza (95%CI) construidos con una aproximacón asimétrica (Greenwood).